BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31134613)

  • 1. Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinoma.
    Yi PS; Shu Y; Bi WX; Zheng XB; Feng WJ; He LY; Li JS
    J Cell Physiol; 2019 Dec; 234(12):21479-21484. PubMed ID: 31134613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A20 inhibits the motility of HCC cells induced by TNF-α.
    Wang X; Ma C; Zong Z; Xiao Y; Li N; Guo C; Zhang L; Shi Y
    Oncotarget; 2016 Mar; 7(12):14742-54. PubMed ID: 26909601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death.
    Catrysse L; Farhang Ghahremani M; Vereecke L; Youssef SA; Mc Guire C; Sze M; Weber A; Heikenwalder M; de Bruin A; Beyaert R; van Loo G
    Cell Death Dis; 2016 Jun; 7(6):e2250. PubMed ID: 27253414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.
    Zhang W; Zhangyuan G; Wang F; Jin K; Shen H; Zhang L; Yuan X; Wang J; Zhang H; Yu W; Huang R; Xu X; Yin Y; Zhong G; Lin A; Sun B
    Immunity; 2021 Jun; 54(6):1168-1185.e8. PubMed ID: 34038747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
    Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
    Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism.
    Longo CR; Patel VI; Shrikhande GV; Scali ST; Csizmadia E; Daniel S; Sun DW; Grey ST; Arvelo MB; Ferran C
    Hepatology; 2005 Jul; 42(1):156-64. PubMed ID: 15962316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
    Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
    Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The zinc finger protein GATA4 induces mesenchymal-to-epithelial transition and cellular senescence through the nuclear factor-κB pathway in hepatocellular carcinoma.
    Xiang Q; Zhou D; He X; Fan J; Tang J; Qiu Z; Zhang Y; Qiu J; Xu Y; Lai G
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2196-2205. PubMed ID: 30995348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.
    Sun L; Feng L; Cui J
    Diagn Pathol; 2018 Sep; 13(1):72. PubMed ID: 30219077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells.
    Jing Y; Sun K; Liu W; Sheng D; Zhao S; Gao L; Wei L
    Cancer Lett; 2018 Oct; 434():22-32. PubMed ID: 29981431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis.
    Donthamsetty S; Bhave VS; Mars WM; Bowen WC; Orr A; Haynes MM; Wu C; Michalopoulos GK
    PLoS One; 2013; 8(9):e74625. PubMed ID: 24058607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells.
    Liu D; Wu J; Liu M; Yin H; He J; Zhang B
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1215-1221. PubMed ID: 26210453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the emerging role of exosome in hepatocellular carcinoma.
    Abudoureyimu M; Zhou H; Zhi Y; Wang T; Feng B; Wang R; Chu X
    Cell Prolif; 2019 Mar; 52(2):e12541. PubMed ID: 30397975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-κB suppressor.
    Yu J; Lee HS; Lee SM; Yu HC; Moon WS; Chung MJ; Park JW; Park BH
    J Hepatol; 2011 Aug; 55(2):328-36. PubMed ID: 21167234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Road to stemness in hepatocellular carcinoma.
    Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
    World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma.
    Fang JZ; Li C; Liu XY; Hu TT; Fan ZS; Han ZG
    PLoS One; 2015; 10(11):e0143042. PubMed ID: 26569409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells.
    Yin L; Fang Z; Shen NJ; Qiu YH; Li AJ; Zhang YJ
    Drug Des Devel Ther; 2017; 11():2841-2850. PubMed ID: 29033545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of neuronal zinc finger protein A20 expression is required for electroacupuncture to attenuate the cerebral inflammatory injury mediated by the nuclear factor-kB signaling pathway in cerebral ischemia/reperfusion rats.
    Zhan J; Qin W; Zhang Y; Jiang J; Ma H; Li Q; Luo Y
    J Neuroinflammation; 2016 Oct; 13(1):258. PubMed ID: 27716383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
    Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
    BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.